12-Dec-2006 - Biologic drug manufacturing is slowly starting to take off in Singapore and is expected to be a key component of the country's drug manufacturing activity in the future.
12-Dec-2006 - The first radio frequency identification (RFID) tag that can resist gamma irradiation has been developed to track pharmaceutical products early on and throughout the supply chain.
11-Dec-2006 - Biotech drugmaker Auxilium has temporarily suspended Phase III clinical trials to investigate a manufacturing problem with its new injectable enzyme batch, which could potentially cost the firm $1m (€750,000).
08-Dec-2006 - PerkinElmer strengthens its position in the cell analysis instrumentation market by acquiring Evotec Technologies for approximately €23m.
07-Dec-2006 - Baxter is expanding its lyophilisation capacity at its German facility to support future growth of its contract manufacturing business for anti-cancer drugs.
07-Dec-2006 - Indian pharma firm Panacea Biotec has taken a 10 percent stake in UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m (€1.4m) under a new joint venture deal signed between the two companies.
06-Dec-2006 - New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.
06-Dec-2006 - The UK subsidiary of ProMetic Life Sciences has signed a deal with Novartis to develop a new purification technology for recombinant protein vaccines that is claimed to be more efficient and cheaper than currently used methods.
05-Dec-2006 - Swiss custom manufacturer Lonza and Singapore's BioOne Capital have announced a new joint venture to build a $350m (€263m) large-scale manufacturing facility in Singapore.
05-Dec-2006 - Millipore has introduced a new container film - PureFlex - that ties in with the trend towards increasing use of disposable products within the bioprocessing sector.
05-Dec-2006 - A new cell culture process developed by Biolex Pharmaceuticals produces monoclonal antibodies which are both more potent and more effective.
30-Nov-2006 - Biotech company Progen has decided to manufacture its new anti-cancer drug in-house rather than outsource it in order to save on costs after the FDA gave the thumbs up for the manufacture of the drug for its upcoming phase III clinical trial.
30-Nov-2006 - A new syringe-testing rig has been launched by texture analysis equipment provider, Stable Micro Systems.
29-Nov-2006 - The necessity for drug manufacturers to comply with increasingly rigorous regulations is driving laboratory information management systems (LIMS) growth, according a new study.
29-Nov-2006 - New Zealand-owned drug maker Biopharm will shut its doors after running out of money.
27-Nov-2006 - Leading drug manufacturer Novartis is set to appeal following failure to gain approval for their anti-fungal treatment Mycograb in the European Union.
24-Nov-2006 - A new X-ray microscopy technique will enable scientists to view materials less than a nanometre in size. The development will help scientists visualise reactions at surfaces, such as corrosion and catalytic reactions, in real-time.
23-Nov-2006 - Baxter has been contracted by the Austrian government to supply 16m doses of pre-pandemic influenza vaccine - enough to vaccinate the country's entire population.
23-Nov-2006 - The growing inhaler device market is driving demand for automated quality control (QC) testing equipment for these products, according to Astech Projects.
21-Nov-2006 - Integra Biosciences is hailing its novel cell culture system as being responsible for dramatically transforming the effectiveness of small-scale antibody production.
21-Nov-2006 - Drug giant GlaxoSmithKline (GSK) has been awarded a contract with the US government to supply 800,000 doses of flu vaccine to the US, where a bird flu pandemic still remains a threat.
20-Nov-2006 - General Electric (GE) has launched a range of ultra-high-performance plastics that it claims will answer the need for cost-effective injection moldable resin.
16-Nov-2006 - Sunnex has launched a new range of stainless steel machinery mounts for pharma manufacturing equipment that are said to cut particle emissions.
15-Nov-2006 - Two Swedish firms have joined together to make an investigational protein-based allergy drug for Phase III trials.
15-Nov-2006 - Pharma companies struggling to choose a suitable contract manufacturer to aseptically produce injectable final drug products (FDP) may now have the support they need thanks to a new guide released this week.